84 related articles for article (PubMed ID: 17426658)
1. Elastolytic matrix metalloproteinases and coronary outcome in children with Kawasaki disease.
Lau AC; Rosenberg H; Duong TT; McCrindle BW; Yeung RS
Pediatr Res; 2007 Jun; 61(6):710-5. PubMed ID: 17426658
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases.
Senzaki H
Arch Dis Child; 2006 Oct; 91(10):847-51. PubMed ID: 16990356
[TBL] [Abstract][Full Text] [Related]
3. [Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease].
Chen R; Zhang AR; Zhao XX; Li ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):989-91. PubMed ID: 20113606
[TBL] [Abstract][Full Text] [Related]
4. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.
Gavin PJ; Crawford SE; Shulman ST; Garcia FL; Rowley AH
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):576-81. PubMed ID: 12692003
[TBL] [Abstract][Full Text] [Related]
5. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery aneurysms in Kawasaki disease: the Puerto Rican experience.
Villavicencio R; Sánchez-Rosetti J
P R Health Sci J; 1987 Apr; 6(1):7-12. PubMed ID: 3615799
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease.
Lau AC; Duong TT; Ito S; Yeung RS
Arthritis Rheum; 2008 Mar; 58(3):854-63. PubMed ID: 18311803
[TBL] [Abstract][Full Text] [Related]
8. Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with Kawasaki disease.
Korematsu S; Ohta Y; Tamai N; Takeguchi M; Goto C; Miyahara H; Kawano T; Izumi T
Pediatr Infect Dis J; 2012 Sep; 31(9):973-4. PubMed ID: 22895216
[TBL] [Abstract][Full Text] [Related]
9. [Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms].
Caballero-Mora FJ; Alonso-Martín B; Tamariz-Martel-Moreno A; Cano-Fernández J; Sánchez-Bayle M
An Pediatr (Barc); 2011 Apr; 74(4):232-8. PubMed ID: 21296631
[TBL] [Abstract][Full Text] [Related]
10. Sudden death caused by coronary artery aneurysms: a late complication of Kawasaki disease.
Wreford FS; Conradi SE; Cohle SD; Lie JT; Dana SE; Puri S
J Forensic Sci; 1991 Jan; 36(1):51-9. PubMed ID: 2007880
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.
Lau AC; Duong TT; Ito S; Yeung RS
Arthritis Rheum; 2009 Jul; 60(7):2131-41. PubMed ID: 19565485
[TBL] [Abstract][Full Text] [Related]
12. [Multiplane 2D-echocardiograms of the coronary arteries in Kawasaki disease].
Zhu Q; Tang SC; Yang F
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Oct; 16(5):289-90, 318. PubMed ID: 3234219
[No Abstract] [Full Text] [Related]
13. MR imaging of coronary artery aneurysms in a child with Kawasaki disease.
Bisset GS; Strife JL; McCloskey J
AJR Am J Roentgenol; 1989 Apr; 152(4):805-7. PubMed ID: 2784264
[No Abstract] [Full Text] [Related]
14. Infliximab as a novel therapy for refractory Kawasaki disease.
Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
[TBL] [Abstract][Full Text] [Related]
15. [Kawasaki disease: heart disease during childhood].
Schroh AM; Domínguez P; Laghezza LB; Melonari PA; Olguín M; Miatello R
Rev Esp Cardiol; 2006 Apr; 59(4):387-90. PubMed ID: 16709393
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.
Liu AM; Ghazizadeh M; Onouchi Z; Asano G
Microvasc Res; 1999 Jul; 58(1):10-27. PubMed ID: 10388599
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy.
Senzaki H; Kobayashi T; Nagasaka H; Nakano H; Kyo S; Yokote Y; Sasakid N
Pediatr Res; 2003 Jun; 53(6):983-8. PubMed ID: 12621103
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery aneurysms after kawasaki disease in a patient with a single coronary artery.
Muta H; Ishii M; Matsuishi T
Pediatr Cardiol; 2002; 23(5):568-9. PubMed ID: 12189416
[No Abstract] [Full Text] [Related]
19. [Unusually early onset of Kawasaki syndrome with coronary artery aneurysms].
Schulz R; Vogt J; Lüders D
Monatsschr Kinderheilkd; 1988 May; 136(5):260-3. PubMed ID: 3405227
[TBL] [Abstract][Full Text] [Related]
20. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
